Timetric's "IntelGenx Technologies Corp. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, recent developments, key employees as well as company locations and subsidiaries.
This report is a crucial resource for industry executives and anyone looking to access key information about "IntelGenx Technologies Corp."
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Identifies crucial company information about "IntelGenx Technologies Corp." along with major products and services for business intelligence requirements.
Provides key ratios on company's financial performance.
Identifies key employees to assist with key business decisions.
Provides annual and interim financial ratios.
Reasons To Buy
Enhance your understanding of "IntelGenx Technologies Corp."
Increase business/sales activities by understanding customers’ businesses better.
Recognize potential partnerships and suppliers.
Qualify prospective partners, affiliates or suppliers.
Acquire up-to-date company information and an understanding of the company’s financial health.
IntelGenx Technologies is engaged in the development of novel and orally administered products based on proprietary oral drug delivery technologies. Its product development is based upon three delivery platform technologies: VersaTab, a Multilayer Tablet technology; VersaFilm, an Oral Film technology; and AdVersa, a Mucoadhesive Tablet technology. Its Multilayer Tablet platform technology allows for the development of oral controlled-release products. The Oral Film technology allows for the instant delivery of pharmaceuticals to the oral cavity, while the Mucoadhesive Tablet allows for the controlled release of active substances to the oral mucosa. The Multilayer Tablet platform technology represents a new generation of controlled release layered tablets designed to modulate the release of active compounds. IntelGenx Technologies also provides product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. The company operates in Canada and the US. It is headquartered in Montreal, Canada.